Neoadjuvant treatment vs no neoadjuvant treatment
Adverse events, · stage III and IV cutaneous melanoma
It is very uncertain whether neoadjuvant treatment changes adverse events, compared with no neoadjuvant treatment (very low certainty).
1 finding from 1 review
- Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes onlyRR 1.582 studies · 162 participantsVery low